EA200870603A1 - Лечение опухолей у педиатрических пациентов антагонистами рецептора эпидермального фактора роста - Google Patents

Лечение опухолей у педиатрических пациентов антагонистами рецептора эпидермального фактора роста

Info

Publication number
EA200870603A1
EA200870603A1 EA200870603A EA200870603A EA200870603A1 EA 200870603 A1 EA200870603 A1 EA 200870603A1 EA 200870603 A EA200870603 A EA 200870603A EA 200870603 A EA200870603 A EA 200870603A EA 200870603 A1 EA200870603 A1 EA 200870603A1
Authority
EA
Eurasian Patent Office
Prior art keywords
tumors
antagonists
treatment
epidermal growth
pediatric patients
Prior art date
Application number
EA200870603A
Other languages
English (en)
Russian (ru)
Inventor
Эрик Ровински
Original Assignee
Имклоун Системз Инкорпорейтед
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Имклоун Системз Инкорпорейтед filed Critical Имклоун Системз Инкорпорейтед
Publication of EA200870603A1 publication Critical patent/EA200870603A1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A61K39/39533—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals
    • A61K39/39558—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals against tumor tissues, cells, antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4745—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Mycology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Oncology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
EA200870603A 2006-07-27 2007-07-26 Лечение опухолей у педиатрических пациентов антагонистами рецептора эпидермального фактора роста EA200870603A1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US83348706P 2006-07-27 2006-07-27
PCT/US2007/074448 WO2008014386A2 (en) 2006-07-27 2007-07-26 Treatment of tumors in pediatric patients with epidermal growth factor receptor antagonists

Publications (1)

Publication Number Publication Date
EA200870603A1 true EA200870603A1 (ru) 2009-06-30

Family

ID=38982334

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200870603A EA200870603A1 (ru) 2006-07-27 2007-07-26 Лечение опухолей у педиатрических пациентов антагонистами рецептора эпидермального фактора роста

Country Status (15)

Country Link
EP (1) EP2043688A4 (es)
JP (1) JP2009544736A (es)
KR (1) KR20090033841A (es)
CN (1) CN101484186A (es)
AU (1) AU2007279261A1 (es)
BR (1) BRPI0712368A2 (es)
CA (1) CA2654911A1 (es)
CR (1) CR10486A (es)
EA (1) EA200870603A1 (es)
EC (1) ECSP089011A (es)
MX (1) MX2008016187A (es)
NO (1) NO20085182L (es)
TN (1) TNSN08512A1 (es)
WO (1) WO2008014386A2 (es)
ZA (1) ZA200810600B (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR112021019167A2 (pt) * 2019-03-27 2021-12-21 Nat Res Council Canada Anticorpos anti-egfrviii e fragmentos de ligação a antígeno dos mesmos

Also Published As

Publication number Publication date
NO20085182L (no) 2009-04-24
AU2007279261A1 (en) 2008-01-31
JP2009544736A (ja) 2009-12-17
KR20090033841A (ko) 2009-04-06
MX2008016187A (es) 2009-01-20
CN101484186A (zh) 2009-07-15
CR10486A (es) 2009-02-23
TNSN08512A1 (en) 2010-04-14
ECSP089011A (es) 2009-01-30
ZA200810600B (en) 2009-11-25
WO2008014386A3 (en) 2008-07-03
BRPI0712368A2 (pt) 2012-06-05
EP2043688A4 (en) 2009-11-11
WO2008014386A2 (en) 2008-01-31
EP2043688A2 (en) 2009-04-08
CA2654911A1 (en) 2008-01-30

Similar Documents

Publication Publication Date Title
MX2009006779A (es) Antagonistas especificos para terapia con adyuvantes y neo-adyuvantes y el tratamiento de tumores en etapa temprana.
BRPI0908635B8 (pt) composto e/ou um sal farmaceuticamente aceitável do mesmo e composição farmacêutica
RS54156B1 (en) COMBINED THERAPY INCLUDING ALFA5BETA1 ANTAGONISTS
RU2013148721A (ru) Комбинации соединений, ингибирующих акт и вемурафениба и способы их применения
EA201791669A2 (ru) Новые терапевтические подходы в лечении смт и связанных с ней расстройств
CL2008001932A1 (es) Compuestos derivados de 6-cicloamino-3-(piridin-4-il)imidazo[1,2-b]piridazina, inhibidores de cq1epsilon y/o ck1delta; procedimiento de preparacion; composicion farmaceutica que los comprende; y uso en el tratamiento de desordenes del sueno, trastorno del ritmo circadiano, cancer y enfermedad de alzheimer.
HK1120441A1 (en) Drugs for treatment of ovarian cancer
EA200970953A1 (ru) СПЕЦИФИЧНЫЕ ИНГИБИТОРЫ PDGFRβ
BRPI0418745A (pt) anticorpo linhagem de células, composição farmacêutica, e, método de tratamento de cáncer em um paciente
NZ587706A (en) Combinations of an anti-her2 antibody-drug conjugate and chemotherapeutic agents, and methods of use
MX2007004549A (es) Tratamiento combinado con bortezomib y un inhibidor de cinasa del receptor del factor de crecimiento epidermico.
TW200634026A (en) Antiangiogenesis therapy of autoimmune disease in patients who have failed prior therapy
NZ712184A (en) Combination therapy comprising a b-raf inhibitor and a second inhibitor
EP1781296A4 (en) QUINAZOLINE DERIVATIVES, USE THEREOF IN THE TREATMENT OF THROMBOCYTHEMIA
NZ598145A (en) Folate-targeted diagnostics and treatment
WO2006110176A3 (en) Combined treatment with radiation and an epidermal growth factor receptor kinase inhibitor
MX2009006574A (es) Tratamiento de cancer de pulmon.
EA201101651A1 (ru) Непрерывное введение интегриновых лигандов для лечения рака
MX2009003532A (es) Tratamiento de hiperbilirrubinemia infantil utilizando bajas dosis de estansoporfina.
CY1118486T1 (el) Λαπατινιμπη για τη θεραπεια του καρκινου
TN2009000136A1 (en) Sequential combination therapy
RU2013126036A (ru) Способ лечения опухолей
EA200870603A1 (ru) Лечение опухолей у педиатрических пациентов антагонистами рецептора эпидермального фактора роста
TR200902344T1 (tr) Anti-epidermal büyüme faktörü reseptör antikorları ile terapinin etkisinin geliştirilmesi için terapötik bileşimler.
MX2009006670A (es) Composicion farmaceutica que usa el aliskiren y el avosentan.